Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ruiz-Cabello

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Seminars in Cancer Biology|February 1, 1991
MHC expression on human tumors--its relevance for local tumor growth and metastasisF Garrido, F Ruiz-Cabello
International Journal of Clinical Pharmacology Research|January 1, 1986
Serum protein binding of model acidic drugs in smokers and non-smokersF Ruiz-Cabello, S Erill
Clinical Pharmacology and Therapeutics|November 1, 1984
Abnormal serum protein binding of acidic drugs in diabetes mellitusF Ruiz-Cabello, S Erill
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Dexamethasone induces altered binding of regulatory factors to HLA class I enhancer sequence in MCF-7 breast tumour cell lineF Rodriguez, M Redondo, F Ruiz-Cabello
Immunology Letters|August 1, 1991
MHC antigens on human tumorsF Ruiz-Cabello, E Klein, F Garrido
Scandinavian Journal of Immunology|April 1, 1995
Biological implications of HLA-DR expression in tumoursT Cabrera, F Ruiz-Cabello, F Garrido
Immunogenetics|January 1, 1994
Upmodulation by estrogen of HLA class I expression in breast tumor cell linesF Rodríguez, F Perán, F Garrido, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?A Concha, T Cabrera, F Ruiz-Cabello, et al.
Scandinavian Journal of Immunology|August 1, 1991
Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumoursT Cabrera, A Concha, F Ruiz-Cabello, et al.
Acta Otorrinolaringologica Espanola|September 1, 1990
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens]F Esteban, A Concha, F Ruiz-Cabello, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Seminars in Cancer Biology|February 1, 1991
MHC expression on human tumors--its relevance for local tumor growth and metastasisF Garrido, F Ruiz-Cabello
International Journal of Clinical Pharmacology Research|January 1, 1986
Serum protein binding of model acidic drugs in smokers and non-smokersF Ruiz-Cabello, S Erill
Clinical Pharmacology and Therapeutics|November 1, 1984
Abnormal serum protein binding of acidic drugs in diabetes mellitusF Ruiz-Cabello, S Erill
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Dexamethasone induces altered binding of regulatory factors to HLA class I enhancer sequence in MCF-7 breast tumour cell lineF Rodriguez, M Redondo, F Ruiz-Cabello
Immunology Letters|August 1, 1991
MHC antigens on human tumorsF Ruiz-Cabello, E Klein, F Garrido
Scandinavian Journal of Immunology|April 1, 1995
Biological implications of HLA-DR expression in tumoursT Cabrera, F Ruiz-Cabello, F Garrido
Immunogenetics|January 1, 1994
Upmodulation by estrogen of HLA class I expression in breast tumor cell linesF Rodríguez, F Perán, F Garrido, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1991
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?A Concha, T Cabrera, F Ruiz-Cabello, et al.
Scandinavian Journal of Immunology|August 1, 1991
Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumoursT Cabrera, A Concha, F Ruiz-Cabello, et al.
Acta Otorrinolaringologica Espanola|September 1, 1990
[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens]F Esteban, A Concha, F Ruiz-Cabello, et al.
Pageof 9